Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Creative Medical Technology Holdings, Inc. (CELZ)
USD0.82
-0.02 (-2.40%)
US NASDAQ Healthcare Biotechnology
Address
211 East Osborn Road 85012
Phoenix, AZ, US
Phoenix, AZ, US
CEO
Timothy Warbington
Website
creativemedicaltechnology.com
IPO
2015-11-06
CIK 1187953 ISIN US22529Y4089
Description
Creative Medical Technology Holdings, Inc., a biotechnology firm based in Phoenix, Arizona, specializes in advancing adult stem cell treatments. The company's core focus spans several medical fields, including immunology, urology, orthopedics, and neurology. Among its therapeutic offerings are CaverStem, designed to address erectile dysfunction; FemCelz, which aims to restore genital sensitivity and alleviate dryness; StemSpine, developed to treat chronic lower back pain; ImmCelz, intended for stroke patients; and OvaStem, a solution for female infertility.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD0.82
-0.02 (-2.40%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
100.6K
Beta
1.83
Float Shares
2.38M
Free Float %
92.4%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -5.63% | -3.11% | +1.87% | +19.13% | -27.09% | +11.22% | +10.10% | -66.97% | -98.52% | -100.00% | -99.97% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (1 ratings, all time)
Buy
Price Targets & DCF
Current price
0.82
DCF (Unlevered)
2.94
+258.3%
DCF (Levered)
3.02
+267.1%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
100% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
-6.00
Distress
Piotroski F-Score
1 / 9
Weak
MOAT Score
0 / 10
No MOAT
Composite Rating
C+
Overall Score
2 / 5
Medium
DCF Score
4 / 5
High
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
5 / 5
High
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%-45.5% Q1'26: -100.0% (vs Q1'25)
-
EPS growth Biotechnology: +29.7%+32.1% ★ Q1'26: +54.2% (vs Q1'25)
-
FCF margin FCF growth · Biotechnology: +16.2%-100,102.6%
-
EBIT margin Biotechnology: +0.0%-102,380.2%
-
ROIC Biotechnology: -16.1%-1,940.7% Q1'26: -2,049.7% (vs Q1'25)
-
Share dilution Biotechnology: -3.4%+61.0% Q1'26: +86.9% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×0.00× Q1'26: 0.00× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
Dec 2029 1 Rev. Ana. 1 EPS Ana. |
Dec 2030 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|
| Revenue |
88.6K
est: 400.0K (-77.9%)
|
9.0K
est: 10.0K (-10.0%)
|
11.0K
est: 8.0K (+37.5%)
|
6.0K
est: 3.0K (+100.0%)
|
23.41M
23.41M – 23.41M
+780,166.7% YoY
|
33.83M
33.83M – 33.83M
+44.5% YoY
|
60.08M
60.08M – 60.08M
+77.6% YoY
|
82.97M
82.97M – 82.97M
+38.1% YoY
|
104.95M
104.95M – 104.95M
+26.5% YoY
|
| EBITDA |
-10.15M
est: -240.0K (-4,130.1%)
|
-5.53M
est: -6.0K (-91,992.5%)
|
-5.63M
est: -4.8K (-117,262.7%)
|
-6.02M
est: -1.8K (-334,315.9%)
|
-14.04M
-14.04M – -14.04M
-780,166.7% YoY
|
-20.30M
-20.30M – -20.30M
-44.5% YoY
|
-36.05M
-36.05M – -36.05M
-77.6% YoY
|
-49.78M
-49.78M – -49.78M
-38.1% YoY
|
-62.97M
-62.97M – -62.97M
-26.5% YoY
|
| EBIT |
-10.24M
est: -240.0K (-4,168.5%)
|
-5.62M
est: -6.0K (-93,568.9%)
|
-5.74M
est: -4.8K (-119,563.8%)
|
-6.14M
est: -1.8K (-341,167.4%)
|
-14.04M
-14.04M – -14.04M
-780,166.7% YoY
|
-20.30M
-20.30M – -20.30M
-44.5% YoY
|
-36.05M
-36.05M – -36.05M
-77.6% YoY
|
-49.78M
-49.78M – -49.78M
-38.1% YoY
|
-62.97M
-62.97M – -62.97M
-26.5% YoY
|
| Net Income |
-10.14M
est: -6.66M (-52.3%)
|
-5.29M
est: -5.45M (+3.0%)
|
-5.49M
est: -7.60M (+27.7%)
|
-6.00M
est: -4.86M (-23.3%)
|
-3.74M
-3.74M – -3.74M
+23.0% YoY
|
-3.60M
-3.60M – -3.60M
+3.8% YoY
|
8.51M
8.51M – 8.51M
+336.4% YoY
|
11.39M
11.39M – 11.39M
+33.9% YoY
|
11.99M
11.99M – 11.99M
+5.2% YoY
|
| SGA |
3.94M
est: 62.03M (-93.6%)
|
3.56M
est: 1.55M (+129.6%)
|
3.24M
est: 2.23M (+45.1%)
|
3.76M
est: 837.4K (+349.4%)
|
6.53B
6.53B – 6.53B
+780,167.4% YoY
|
9.44B
9.44B – 9.44B
+44.5% YoY
|
16.77B
16.77B – 16.77B
+77.6% YoY
|
23.16B
23.16B – 23.16B
+38.1% YoY
|
29.29B
29.29B – 29.29B
+26.5% YoY
|
| EPS |
-9.28
est: -4.50 (-106.2%)
|
-3.76
est: -3.68 (-2.2%)
|
-3.71
est: -3.19 (-16.3%)
|
-2.52
est: -2.04 (-23.5%)
|
-1.57
-1.57 – -1.57
+23.0% YoY
|
-1.51
-1.51 – -1.51
+3.8% YoY
|
3.57
3.57 – 3.57
+336.4% YoY
|
4.78
4.78 – 4.78
+33.9% YoY
|
5.03
5.03 – 5.03
+5.2% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-08 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-07 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-06 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-05 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-04 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-01 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-30 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-29 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-28 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-27 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-24 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-23 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-22 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-21 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-20 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-17 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-16 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
Owner Earnings
Owner's Earnings (history)
Owner's Earnings history not available.
Owner alignment
Owner's Earnings TTM
—
OE per share TTM
—
Owner's Yield
—
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
—
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
10
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Timothy Herbst | 10.35M | 10.35% | 10.35M | — | 10.35M | — | IN | USA | 2016-08-23 | ↗ |
| 2 | John Markey | 717.6K | 5.10% | 717.6K | — | 717.6K | — | IN | Ohio, United States | 2023-05-02 | ↗ |
| 3 | S | 332.3K | 4.90% | — | 332.3K | — | 332.3K | CO | Cayman Islands | 2022-02-14 | ↗ |
| 4 | L1 Capital Global Opportunities Master Fund Ltd. | 327.5K | 5.10% | 327.5K | — | — | — | FI | Cayman Islands | 2021-12-08 | ↗ |
| 5 | CVI Investments, Inc. | 326.5K | 5.20% | — | — | — | 326.5K | CO | Cayman Islands | 2021-12-10 | ↗ |
| 6 | Heights Capital Management, Inc. | 326.5K | 5.20% | — | — | — | 326.5K | CO | Cayman Islands | 2021-12-10 | ↗ |
| 7 | Growth GP, LLC | 85.5K | 5.70% | — | 85.5K | — | — | OO | United States of America | 2021-12-20 | ↗ |
| 8 | Altium Capital Management, LP | 85.5K | 4.99% | — | 85.5K | — | — | IA, PN | Delaware, United States of America | 2022-02-14 | ↗ |
| 9 | Altium Growth Fund, LP | 85.5K | 4.99% | — | 85.5K | — | — | OO | Delaware, United States of America | 2022-02-14 | ↗ |
| 10 | Altium Growth GP, LLC | 85.5K | 4.99% | — | 85.5K | — | — | PN | Delaware, United States of America | 2022-02-14 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
Held by 1 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Vanguard Extended Market ETF VXF | 0.00% | 44.8K | 0.05% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Ratio by volume
0.00
Bearish
Buys
0
Sells
2
Shares acquired
—
Shares disposed
1.5K
Cash buys
—
Cash sales
2.00
Net activity
-1,500
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-02-19 | Finger Michael H. | Director | S-Sale | D | Common Stock | 750 | 5.75 | 4.3K | 351 | D | ↗ |
| 2025-02-18 | Finger Michael H. | Director | S-Sale | D | Common Stock | 750 | 5.00 | 3.8K | 1,101 | D | ↗ |
| 2023-06-28 | Warbington Timothy | Director / Officer | P-Purchase | A | Common Stock | 200 | 4.36 | 872.00 | 12,209 | — | ↗ |
| 2023-06-27 | Warbington Timothy | Director / Officer | P-Purchase | A | Common Stock | 200 | 4.48 | 896.00 | 12,009 | — | ↗ |
| 2022-11-22 | Warbington Timothy | Director | P-Purchase | A | Common Stock | 200 | 0.38 | 75.42 | 112,087 | — | ↗ |
| 2022-11-21 | Warbington Timothy | Director | P-Purchase | A | Common Stock | 5,000 | 0.39 | 2.0K | 102,087 | — | ↗ |
| 2022-09-27 | Warbington Timothy | Director / Officer | P-Purchase | A | Common Stock | 20,000 | 0.50 | 10.0K | 87,087 | — | ↗ |
| 2022-09-27 | Finger Michael H. | Director | P-Purchase | A | Common Stock | 2,000 | 0.50 | 1.0K | 18,502 | — | ↗ |
| 2022-09-22 | Warbington Timothy | Director / Officer | P-Purchase | A | Common Stock | 12,000 | 0.54 | 6.5K | 67,087 | — | ↗ |
| 2022-09-21 | Warbington Timothy | Director / Officer | P-Purchase | A | Common Stock | 20,000 | 0.61 | 12.1K | 55,087 | — | ↗ |
| 2022-06-14 | Finger Michael H. | Director | P-Purchase | A | Common Stock | 10,000 | 0.70 | 7.0K | 16,502 | — | ↗ |
| 2022-06-06 | Warbington Timothy | Director / Officer | P-Purchase | A | Common Stock | 15,000 | 0.91 | 13.7K | 25,087 | — | ↗ |
| 2022-05-20 | Finger Michael H. | Director | P-Purchase | A | Common Stock | 6,500 | 1.50 | 9.8K | 6,502 | — | ↗ |
| 2022-02-09 | Warbington Timothy | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 58,580 | 1.69 | 99.0K | 58,580 | — | ↗ |
| 2022-02-09 | Dickerson Donald | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 53,237 | 1.69 | 90.0K | 53,237 | — | ↗ |
| 2021-12-02 | Urdang Bruce Steven | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-12-02 | Snow Susan H | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-12-02 | Finger Michael H. | Director | — | D | Common Stock | 0 | 0.00 | — | 2 | — | ↗ |
| 2021-07-22 | Ichim Thomas | Director | S-Sale | D | Common Stock | 1,450,000 | 0.03 | 43.6K | 4,529,522 | — | ↗ |
| 2021-07-21 | Ichim Thomas | Director | S-Sale | D | Common Stock | 1,500,000 | 0.03 | 46.2K | 5,979,522 | — | ↗ |
| 2021-07-20 | Ichim Thomas | Director | S-Sale | D | Common Stock | 1,400,000 | 0.03 | 42.6K | 7,479,522 | — | ↗ |
| 2021-07-15 | Patel Amit Nilkanth | Director | A-Award | A | Warrant to Purchase Common Stock | 5,000,000 | 0.03 | 150.0K | 5,000,000 | — | ↗ |
| 2021-07-15 | Ichim Thomas | Director | A-Award | A | Warrant to Purchase Common Stock | 5,000,000 | 0.03 | 150.0K | 5,000,000 | — | ↗ |
| 2021-07-15 | Dickerson Donald | Director / Officer | A-Award | A | Warrant to Purchase Common Stock | 5,000,000 | 0.03 | 150.0K | 5,000,000 | — | ↗ |
| 2021-06-28 | Ichim Thomas | Director | M-Exempt | D | Warrant to Purchase Common Stock | 10,000,000 | 0.00 | 40.0K | 0 | — | ↗ |
| 2021-01-08 | Warbington Timothy | Director / Officer / 10% Owner | J-Other | A | Common Stock | 44,642,857 | 50,000.00 | 2.23T | 113,474,233 | — | ↗ |
| 2021-01-08 | CREATIVE MEDICAL HEALTH INC. | 10% Owner | J-Other | A | Common Stock | 44,642,857 | 50,000.00 | 2.23T | 113,474,233 | — | ↗ |
| 2020-12-28 | Patel Amit Nilkanth | Director | A-Award | A | Warrant to Purchase Common Stock | 10,000,000 | 0.00 | 40.0K | 10,000,000 | — | ↗ |
| 2020-12-28 | Ichim Thomas | Director | A-Award | A | Warrant to Purchase Common Stock | 10,000,000 | 0.00 | 40.0K | 10,000,000 | — | ↗ |
| 2020-12-28 | Dickerson Donald | Director / Officer | A-Award | A | Warrant to Purchase Common Stock | 10,000,000 | 0.00 | 40.0K | 10,000,000 | — | ↗ |
| 2020-09-30 | Warbington Timothy | Director / Officer / 10% Owner | J-Other | A | Common Stock | 42,328,042 | 40,000.00 | 1.69T | 68,831,376 | — | ↗ |
| 2020-09-30 | CREATIVE MEDICAL HEALTH INC. | 10% Owner | J-Other | A | Common Stock | 42,328,042 | 40,000.00 | 1.69T | 68,831,376 | — | ↗ |
| 2020-06-03 | Warbington Timothy | Director / Officer / 10% Owner | J-Other | A | Common Stock | 19,736,842 | 0.00 | 75.0K | 26,503,334 | — | ↗ |
| 2020-06-03 | CREATIVE MEDICAL HEALTH INC. | 10% Owner | J-Other | A | Common Stock | 19,736,842 | 0.00 | 75.0K | 26,503,334 | — | ↗ |
| 2020-02-17 | Warbington Timothy | Director / Officer / 10% Owner | J-Other | A | Common Stock | 2,250,000 | 0.02 | 45.0K | 6,766,492 | — | ↗ |
| 2020-02-17 | CREATIVE MEDICAL HEALTH INC. | 10% Owner | J-Other | A | Common Stock | 2,250,000 | 0.02 | 45.0K | 6,766,492 | — | ↗ |
| 2019-12-13 | Warbington Timothy | Director / Officer / 10% Owner | J-Other | A | Common Stock | 500,000,000 | 0.00 | 50.0K | 677,473,616 | — | ↗ |
| 2019-12-13 | CREATIVE MEDICAL HEALTH INC. | 10% Owner | J-Other | A | Common Stock | 500,000,000 | 0.00 | 50.0K | 677,473,616 | — | ↗ |
| 2019-11-05 | Warbington Timothy | Director / Officer / 10% Owner | J-Other | A | Common Stock | 100,000,000 | 0.00 | 50.0K | 177,473,616 | — | ↗ |
| 2019-11-05 | CREATIVE MEDICAL HEALTH INC. | 10% Owner | J-Other | A | Common Stock | 100,000,000 | 0.00 | 50.0K | 177,473,616 | — | ↗ |
| 2019-06-30 | Warbington Timothy | Director / Officer / 10% Owner | J-Other | A | Common Stock | 10,000,000 | 0.01 | 60.0K | 77,473,616 | — | ↗ |
| 2019-06-30 | CREATIVE MEDICAL HEALTH INC. | 10% Owner | J-Other | A | Common Stock | 10,000,000 | 0.01 | 60.0K | 77,473,616 | — | ↗ |
| 2018-10-17 | Warbington Timothy | Director / Officer / 10% Owner | C-Conversion | A | Common Stock | 4,444,444 | 0.02 | 100.0K | 72,955,661 | — | ↗ |
| 2018-10-17 | CREATIVE MEDICAL HEALTH INC. | 10% Owner | C-Conversion | A | Common Stock | 4,444,444 | 0.02 | 100.0K | 72,955,661 | — | ↗ |
| 2018-04-11 | Warbington Timothy | Director / Officer / 10% Owner | C-Conversion | A | Common Stock | 9,855,290 | 0.01 | 136.0K | 68,511,217 | — | ↗ |
| 2018-04-11 | CREATIVE MEDICAL HEALTH INC. | 10% Owner | C-Conversion | A | Common Stock | 9,855,290 | 0.01 | 136.0K | 68,511,217 | — | ↗ |
| 2017-08-29 | Warbington Timothy | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 5,000 | 0.20 | 1.0K | 58,655,927 | — | ↗ |
| 2017-08-29 | CREATIVE MEDICAL HEALTH INC. | 10% Owner | S-Sale | D | Common Stock | 5,000 | 0.20 | 1.0K | 58,655,927 | — | ↗ |
| 2017-06-05 | Warbington Timothy | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 2,500 | 0.31 | 775.00 | 58,608,727 | — | ↗ |
| 2017-06-05 | CREATIVE MEDICAL HEALTH INC. | 10% Owner | S-Sale | D | Common Stock | 2,500 | 0.31 | 775.00 | 58,608,727 | — | ↗ |
| 2017-06-02 | Warbington Timothy | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 3,500 | 0.40 | 1.4K | 58,613,427 | — | ↗ |
| 2017-06-02 | CREATIVE MEDICAL HEALTH INC. | 10% Owner | S-Sale | D | Common Stock | 3,500 | 0.40 | 1.4K | 58,613,427 | — | ↗ |
| 2017-05-18 | Warbington Timothy | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 1,400 | 0.45 | 630.00 | 58,616,927 | — | ↗ |
| 2017-05-18 | CREATIVE MEDICAL HEALTH INC. | 10% Owner | S-Sale | D | Common Stock | 1,400 | 0.45 | 630.00 | 58,616,927 | — | ↗ |
| 2016-12-31 | Warbington Timothy | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 2,935,609 | 0.10 | 293.6K | 62,061,059 | — | ↗ |
| 2016-12-31 | CREATIVE MEDICAL HEALTH INC. | 10% Owner | S-Sale | D | Common Stock | 2,935,609 | 0.10 | 293.6K | 62,061,059 | — | ↗ |
| 2016-12-18 | Warbington Timothy | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 3,412,791 | 0.01 | 34.1K | 61,553,876 | — | ↗ |
| 2016-12-18 | CREATIVE MEDICAL HEALTH INC. | 10% Owner | S-Sale | D | Common Stock | 3,412,791 | 0.01 | 34.1K | 61,553,876 | — | ↗ |
| 2016-12-02 | Herbst Timothy | 10% Owner | P-Purchase | A | Warrants | 100,000 | 0.10 | 10.0K | 100,000 | — | ↗ |
| 2016-09-30 | Warbington Timothy | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 300,000 | 0.10 | 30.0K | 64,996,667 | — | ↗ |
| 2016-09-30 | CREATIVE MEDICAL HEALTH INC. | 10% Owner | P-Purchase | A | Common Stock | 300,000 | 0.10 | 30.0K | 64,996,667 | — | ↗ |
| 2016-05-18 | Warbington Timothy | Director / Officer / 10% Owner | — | D | Common Stock | 0 | 0.00 | — | 1,000,000 | — | ↗ |
| 2016-05-18 | WHITE STEVEN L | Director / Officer | S-Sale | D | Common Stock | 15,100,000 | 5,000.00 | 75.50B | 0 | — | ↗ |
| 2016-05-18 | Patel Amit Nilkanth | Director | — | I | Common Stock | 0 | 0.00 | — | 600,000 | — | ↗ |
| 2016-05-18 | Ichim Thomas | Director | — | I | Common Stock | 0 | 0.00 | — | 2,586,667 | — | ↗ |
| 2016-05-18 | Herbst Timothy | 10% Owner | — | D | Common Stock | 0 | 0.00 | — | 10,346,667 | — | ↗ |
| 2016-05-18 | Dickerson Donald | Director / Officer | — | D | Common Stock | 0 | 0.00 | — | 200,000 | — | ↗ |
| 2016-05-18 | CREATIVE MEDICAL HEALTH INC. | 10% Owner | — | D | Common Stock | 0 | 0.00 | — | 10,000,000 | — | ↗ |
| 2009-01-20 | WHITE STEVEN L | Director / Officer | — | D | Common Stock | 0 | 0.00 | — | 15,100,750 | — | ↗ |
Executive team
Top executives
EBIT / Employee
-15.4K
Shares Outstanding
2.58M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2024 | Timothy Warbington Chief Executive Officer | 339.0K | — | — | — | — | 247.5K | 587.2K | 0.00% | ↗ |
| 2 | 2024 | Donald Dickerson Chief Financial Officer | 300.0K | — | — | — | — | 225.0K | 525.0K | 0.00% | ↗ |
| 3 | 2023 | Timothy Warbington Chief Executive Officer | 330.0K | — | — | — | — | 192.6K | 522.6K | 0.00% | ↗ |
| 4 | 2023 | Donald Dickerson Chief Financial Officer | 300.0K | — | — | — | — | 167.3K | 467.3K | 0.00% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Timothy Warbington | Co-Founder, Chairman, President & Chief Executive Officer | 732.7K | male |
| Donald Dickerson | Senior Vice President, Chief Financial Officer & Director | 560.0K | male |
ESG Rating
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for CELZ
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
